Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
NCT02902874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 185
Last updated 2022-05-27
Summary
To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.
Conditions
- ALCL
Interventions
- OTHER
-
Blood sample
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-21
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- France
Study Locations
More Related Trials
-
Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
NCT05237245 ·Status: ACTIVE_NOT_RECRUITING
-
Signal Detection in Monoclonal and New Agents in Lymphoma
NCT02849912 ·Status: COMPLETED
-
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NCT06813573 ·Status: RECRUITING ·Phase: NA
-
A Global Study of the PETAL Consortium
NCT06067347 ·Status: RECRUITING
-
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
NCT01369784 ·Status: COMPLETED
-
A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma
NCT01766583 ·Status: COMPLETED ·Phase: PHASE1
-
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
NCT06526065 ·Status: RECRUITING
-
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
NCT03104478 ·Status: COMPLETED
-
GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma
NCT01659099 ·Status: TERMINATED ·Phase: PHASE3
-
This Trial is a Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphomas
NCT01279772 ·Status: TERMINATED
-
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
NCT06642792 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
NCT03493451 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma
NCT01290120 ·Status: COMPLETED ·Phase: PHASE2
-
Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia
NCT00773149 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
NCT01660776 ·Status: COMPLETED
-
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
NCT04696692 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
NCT01488162 ·Status: COMPLETED
-
A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
NCT00169156 ·Status: COMPLETED ·Phase: PHASE2
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
NCT00896519 ·Status: UNKNOWN ·Phase: PHASE2
-
Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas
NCT06089941 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas
NCT04520529 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
NCT02618109 ·Status: TERMINATED ·Phase: PHASE4
-
Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans
NCT01287923 ·Status: COMPLETED